Your browser doesn't support javascript.
loading
Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.
Fukushima, Taito; Morimoto, Manabu; Kobayashi, Satoshi; Ueno, Makoto; Uojima, Haruki; Hidaka, Hisashi; Kusano, Chika; Chuma, Makoto; Numata, Kazushi; Tsuruya, Kota; Arase, Yoshitaka; Kagawa, Tatehiro; Hattori, Nobuhiro; Ikeda, Hiroki; Watanabe, Tsunamasa; Tanaka, Katsuaki; Maeda, Shin.
Afiliação
  • Fukushima T; Division of Hepatobiliary and Pancreatic Oncology, Kanagawa Cancer Center, Yokohama, Japan.
  • Morimoto M; Division of Hepatobiliary and Pancreatic Oncology, Kanagawa Cancer Center, Yokohama, Japan.
  • Kobayashi S; Division of Hepatobiliary and Pancreatic Oncology, Kanagawa Cancer Center, Yokohama, Japan.
  • Ueno M; Division of Hepatobiliary and Pancreatic Oncology, Kanagawa Cancer Center, Yokohama, Japan.
  • Uojima H; Department of Gastroenterology, Internal Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
  • Hidaka H; Department of Gastroenterology, Internal Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
  • Kusano C; Department of Gastroenterology, Internal Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
  • Chuma M; Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan.
  • Numata K; Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan.
  • Tsuruya K; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan.
  • Arase Y; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan.
  • Kagawa T; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan.
  • Hattori N; Division of Gastroenterology and Hepatology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
  • Ikeda H; Division of Gastroenterology and Hepatology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
  • Watanabe T; Division of Gastroenterology and Hepatology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
  • Tanaka K; Gastroenterology Division, Hadano Red Cross Hospital, Hadano, Japan.
  • Maeda S; Department of Gastroenterology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Oncologist ; 28(7): e526-e533, 2023 07 05.
Article em En | MEDLINE | ID: mdl-37023703

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article